The key role of a glucagon-like peptide-1 receptor agonist in body fat redistribution
出版年份 2018 全文链接
标题
The key role of a glucagon-like peptide-1 receptor agonist in body fat redistribution
作者
关键词
-
出版物
JOURNAL OF ENDOCRINOLOGY
Volume -, Issue -, Pages 271-286
出版商
Bioscientifica
发表日期
2018-12-18
DOI
10.1530/joe-18-0374
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Long-chain polyunsaturated fatty acids and extensively hydrolyzed casein-induced browning in a Ucp-1 reporter mouse model of obesity
- (2018) Liufeng Mao et al. Food & Function
- Berberine improves glucogenesis and lipid metabolism in nonalcoholic fatty liver disease
- (2017) Li Zhao et al. BMC Endocrine Disorders
- Novel GLP-1 Analog Supaglutide Reduces HFD-Induced Obesity Associated with Increased Ucp-1 in White Adipose Tissue in Mice
- (2017) Yun Wan et al. Frontiers in Physiology
- GLP-1 analogue improves hepatic lipid accumulation by inducing autophagy via AMPK/mTOR pathway
- (2016) Qin He et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Antiobesity efficacy of GLP-1 receptor agonist liraglutide is associated with peripheral tissue-specific modulation of lipid metabolic regulators
- (2016) Juan Decara et al. BIOFACTORS
- Glucagon-like peptide-1, glucagon-like peptide-2, and lipid metabolism
- (2016) Thomas A. Lutz et al. CURRENT OPINION IN LIPIDOLOGY
- GLP-1 as a target for therapeutic intervention
- (2016) Surya Panicker Rajeev et al. CURRENT OPINION IN PHARMACOLOGY
- Browning of White Fat: Novel Insight Into Factors, Mechanisms, and Therapeutics
- (2016) Nevena Jeremic et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Hypothalamic AMPK: a canonical regulator of whole-body energy balance
- (2016) Miguel López et al. Nature Reviews Endocrinology
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Assessment of body composition in Wistar rat offspring by DXA in relation to prenatal and postnatal nutritional manipulation
- (2016) Makarios Eleftheriades et al. PEDIATRIC RESEARCH
- Neural effects of gut- and brain-derived glucagon-like peptide-1 and its receptor agonist
- (2016) Kenichi Katsurada et al. Journal of Diabetes Investigation
- Long-acting glucagon-like peptide-1 receptor agonists have direct access to and effects on pro-opiomelanocortin/cocaine- and amphetamine-stimulated transcript neurons in the mouse hypothalamus
- (2016) Lotte Bjerre Knudsen et al. Journal of Diabetes Investigation
- BMP4 Cross-talks With Estrogen/ERα Signaling to Regulate Adiposity and Glucose Metabolism in Females
- (2016) Shu-wen Qian et al. EBioMedicine
- Short-term effects of glucagon-like peptide 1 (GLP-1) receptor agonists on fat distribution in patients with type 2 diabetes mellitus: an ultrasonography study
- (2015) Susanna Morano et al. ACTA DIABETOLOGICA
- Role of developmental transcription factors in white, brown and beige adipose tissues
- (2015) Catriona Hilton et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Introduction: Table 1
- (2015) DIABETES CARE
- Central GLP-1 receptor signalling accelerates plasma clearance of triacylglycerol and glucose by activating brown adipose tissue in mice
- (2015) Sander Kooijman et al. DIABETOLOGIA
- Formation and activation of thermogenic fat
- (2015) Jun Wu et al. TRENDS IN GENETICS
- Hypothalamic GLP-1: the control of BAT thermogenesis and browning of white fat
- (2015) Miguel López et al. Adipocyte
- Liraglutide decreases carotid intima-media thickness in patients with type 2 diabetes: 8-month prospective pilot study
- (2014) Manfredi Rizzo et al. Cardiovascular Diabetology
- GLP-1 Agonism Stimulates Brown Adipose Tissue Thermogenesis and Browning Through Hypothalamic AMPK
- (2014) D. Beiroa et al. DIABETES
- The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss
- (2014) Anna Secher et al. JOURNAL OF CLINICAL INVESTIGATION
- Exenatide improves hepatic steatosis by enhancing lipid use in adipose tissue in nondiabetic rats
- (2014) Kosuke Tanaka WORLD JOURNAL OF GASTROENTEROLOGY
- Long-term impact of liraglutide, a glucagon-like peptide-1 (GLP-1) analogue, on body weight and glycemic control in Japanese type 2 diabetes: an observational study
- (2014) Kana Inoue et al. Diabetology & Metabolic Syndrome
- GLP-1 receptor agonism ameliorates hepatic VLDL overproduction and de novo lipogenesis in insulin resistance
- (2014) Jennifer Taher et al. Molecular Metabolism
- Sex dimorphism and depot differences in adipose tissue function
- (2013) Ursula A. White et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Mechanisms and Metabolic Implications of Regional Differences among Fat Depots
- (2013) Tamara Tchkonia et al. Cell Metabolism
- Adiposity and Insulin Resistance in Humans: The Role of the Different Tissue and Cellular Lipid Depots
- (2013) Samantha Hocking et al. ENDOCRINE REVIEWS
- The Role of Gastrointestinal Hormones in Hepatic Lipid Metabolism
- (2013) Jamie Mells et al. SEMINARS IN LIVER DISEASE
- Efficacy of liraglutide, a glucagon-like peptide-1 (GLP-1) analogue, on body weight, eating behavior, and glycemic control, in Japanese obese type 2 diabetes
- (2012) Yuya Fujishima et al. Cardiovascular Diabetology
- A Role for Adipose Tissue De Novo Lipogenesis in Glucose Homeostasis During Catch-up Growth: A Randle Cycle Favoring Fat Storage
- (2012) H. Marcelino et al. DIABETES
- Direct Control of Brown Adipose Tissue Thermogenesis by Central Nervous System Glucagon-Like Peptide-1 Receptor Signaling
- (2012) S. H. Lockie et al. DIABETES
- Long-term efficacy and safety comparison of liraglutide, glimepiride and placebo, all in combination with metformin in type 2 diabetes: 2-year results from the LEAD-2 study
- (2012) M. Nauck et al. DIABETES OBESITY & METABOLISM
- GLP-1 Receptor Activation Indirectly Reduces Hepatic Lipid Accumulation But Does Not Attenuate Development of Atherosclerosis in Diabetic MaleApoE−/−Mice
- (2012) Naim Panjwani et al. ENDOCRINOLOGY
- The effect of glucagon-like peptide 1 on cardiovascular risk
- (2012) Jacob Sivertsen et al. Nature Reviews Cardiology
- Relative shrinkage of adipocytes by paraffin in proportion to plastic embedding in human adipose tissue before and after weight loss
- (2012) Sanne P.M. Verhoef et al. Obesity Research & Clinical Practice
- GLP-1 Receptor Activation Inhibits VLDL Production and Reverses Hepatic Steatosis by Decreasing Hepatic Lipogenesis in High-Fat-Fed APOE*3-Leiden Mice
- (2012) Edwin T. Parlevliet et al. PLoS One
- Short-term effects of liraglutide on visceral fat adiposity, appetite, and food preference: a pilot study of obese Japanese patients with type 2 diabetes
- (2011) Kana Inoue et al. Cardiovascular Diabetology
- Benefits of Modest Weight Loss in Improving Cardiovascular Risk Factors in Overweight and Obese Individuals With Type 2 Diabetes
- (2011) R. R. Wing et al. DIABETES CARE
- Femoral Adipose Tissue May Accumulate the Fat That Has Been Recycled as VLDL and Nonesterified Fatty Acids
- (2010) S. E. McQuaid et al. DIABETES
- Liraglutide, a once-daily human glucagon-like peptide 1 analogue, provides sustained improvements in glycaemic control and weight for 2 years as monotherapy compared with glimepiride in patients with type 2 diabetes
- (2010) A. Garber et al. DIABETES OBESITY & METABOLISM
- Gluteofemoral body fat as a determinant of metabolic health
- (2010) K N Manolopoulos et al. INTERNATIONAL JOURNAL OF OBESITY
- Application of Isotopic Techniques Using Constant Specific Activity or Enrichment to the Study of Carbohydrate Metabolism
- (2009) A. Vella et al. DIABETES
- Weight loss with liraglutide, a once-daily human glucagon-like peptide-1 analogue for type 2 diabetes treatment as monotherapy or added to metformin, is primarily as a result of a reduction in fat tissue
- (2009) J. Jendle et al. DIABETES OBESITY & METABOLISM
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search